The landscape of dementia prognosis has advanced considerably with the arrival of refined biomarkers, such as amyloid PET scans, tau imaging, and blood-based assessments that will detect Alzheimer's pathology years in advance of signs emerge. When these technological improvements characterize impressive progress in understanding neurodegenerative diseases, they may have not https://haynesc667uit6.wikiconversation.com/user